SESTINI, PIERSANTE
 Distribuzione geografica
Continente #
NA - Nord America 15.089
EU - Europa 12.314
AS - Asia 6.976
SA - Sud America 1.162
AF - Africa 327
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 2
Totale 35.905
Nazione #
US - Stati Uniti d'America 14.863
GB - Regno Unito 2.764
SG - Singapore 2.299
CN - Cina 2.298
RU - Federazione Russa 2.188
IT - Italia 1.699
IE - Irlanda 1.644
BR - Brasile 968
SE - Svezia 918
UA - Ucraina 849
FR - Francia 727
VN - Vietnam 702
DE - Germania 635
HK - Hong Kong 615
FI - Finlandia 385
KR - Corea 252
IN - India 228
ZA - Sudafrica 143
ES - Italia 120
CA - Canada 114
BD - Bangladesh 87
NL - Olanda 86
TR - Turchia 85
MX - Messico 70
IQ - Iraq 67
NG - Nigeria 66
JP - Giappone 63
AR - Argentina 62
BE - Belgio 50
CZ - Repubblica Ceca 45
PL - Polonia 44
PK - Pakistan 39
ID - Indonesia 34
EC - Ecuador 33
AT - Austria 31
AU - Australia 26
VE - Venezuela 26
CI - Costa d'Avorio 24
CL - Cile 24
MA - Marocco 24
IR - Iran 18
LT - Lituania 18
UZ - Uzbekistan 18
AZ - Azerbaigian 17
PH - Filippine 17
SA - Arabia Saudita 17
CO - Colombia 15
KE - Kenya 15
IL - Israele 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
GR - Grecia 12
JO - Giordania 12
BG - Bulgaria 11
LB - Libano 11
AL - Albania 10
NP - Nepal 10
PY - Paraguay 10
CH - Svizzera 9
EG - Egitto 9
PA - Panama 9
RO - Romania 9
SN - Senegal 9
TN - Tunisia 9
DK - Danimarca 8
PE - Perù 8
UY - Uruguay 8
KZ - Kazakistan 7
PT - Portogallo 7
EE - Estonia 6
JM - Giamaica 6
MY - Malesia 6
RS - Serbia 6
BO - Bolivia 5
ET - Etiopia 5
EU - Europa 5
HU - Ungheria 5
LV - Lettonia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
CY - Cipro 4
LK - Sri Lanka 4
NI - Nicaragua 4
OM - Oman 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
GE - Georgia 3
GH - Ghana 3
GT - Guatemala 3
HR - Croazia 3
IM - Isola di Man 3
IS - Islanda 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
Totale 35.868
Città #
Southend 2.403
Dublin 1.638
Fairfield 1.610
Dallas 1.545
Singapore 1.464
Ashburn 1.089
Chandler 1.087
Santa Clara 732
Woodbridge 686
Jacksonville 669
Wilmington 641
Moscow 613
Seattle 603
Hong Kong 580
Houston 579
Beijing 557
San Jose 545
Cambridge 514
Ann Arbor 376
Siena 326
Princeton 301
Hefei 299
Seoul 244
The Dalles 242
Nanjing 222
Helsinki 215
Ho Chi Minh City 200
New York 199
Los Angeles 194
Lauterbourg 193
Lastra a Signa 169
Hanoi 161
Council Bluffs 154
Florence 134
Johannesburg 131
Boardman 113
San Mateo 112
Munich 105
San Diego 105
Buffalo 100
Dong Ket 88
Milan 87
São Paulo 87
Nanchang 81
Dearborn 74
Shanghai 74
Chicago 66
Abuja 63
London 63
Redondo Beach 61
Málaga 56
Orem 55
Chennai 53
Columbus 52
Shenyang 52
Tianjin 49
Tokyo 49
Bengaluru 45
Rome 45
Hebei 43
Changsha 38
Frankfurt am Main 38
Montreal 36
Warsaw 36
Fremont 35
Toronto 35
Brussels 34
Phoenix 34
Guangzhou 33
Da Nang 32
Düsseldorf 30
Izmir 30
San Francisco 30
Kunming 29
Jinan 28
Norwalk 28
Nuremberg 27
Manchester 26
Amsterdam 25
Atlanta 25
Rio de Janeiro 25
Abidjan 24
Baghdad 24
Belo Horizonte 24
Boston 24
Brno 24
Turku 24
Curitiba 23
Haiphong 23
Hangzhou 23
Jiaxing 23
Lappeenranta 23
Dhaka 22
Ningbo 22
Washington 22
Zhengzhou 22
Stockholm 21
Brooklyn 20
Mexico City 20
Falls Church 19
Totale 24.174
Nome #
null 398
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 354
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 342
Peripheral biomarkers' panel for severe COVID-19 patients 317
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells:therapeutic implications of cyclophosphamide 306
Pulmonary lymphatic vessel morphology: a review 301
Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung 290
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6 289
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 281
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 280
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 276
Antigen-induced lung solute clearance in rats is dependent on capsaicin-sensitive nerves 265
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 262
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 255
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 252
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 250
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 246
Ambulatory oxygen in fibrotic lung disease (AmbOx): Study protocol for a randomised controlled trial 245
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 243
Omalizumab treatment in Samter's triad: case series and review of the literature 242
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 236
Serum amyloid A in patients with idiopathic pulmonary fibrosis 236
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 236
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 234
Indoor air quality, ventilation and respiratory health in elderly residents living in nursing homes in Europe 234
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 231
Could NSAIDs have a role as antiasthmatic agents? 229
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 226
[Evaluation of NAD glycohydrolase in leukocytes from peripheral blood and broncho-alveolar lavage in man]. 225
Ambulatory oxygen in interstitial lung disease 223
NK and NKT-like cells in granulomatous and fibrotic lung diseases 220
Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes 219
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 219
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 219
Consumption of fresh fruit rich in vitamin C and wheezing symptoms in children 218
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 216
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 215
School air quality related to dry cough, rhinitis and nasal patency in children 214
Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994-2002 211
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 211
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease 211
Systemic sclerosis sera affect fibrillin-1 deposition and focal adhesion molecule expression by dermal blood microvascular endothelial cells: Therapeutic implications of cyclophosphamide 210
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 210
A multicentre controlled trial of terfenadine, dexchlorpheniramine, and placebo in allergic rhinitis. 209
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 207
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 205
Acoustic parameters of voluntary cough in healthy non-smoking subjects 204
Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use 202
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 202
A survey on hospitalised community-acquired pneumonia in Italy 202
Postoperative acute kidney injury in lung transplant recipients 202
Serum amyloid A: A potential biomarker of lung disorders 201
Extracorporeal Photopheresis in Lung Transplantation 200
Endothelin axis polymorphisms in patients with scleroderma 198
Short-acting beta2-agonists for stable chronic obstructive pulmonary disease 198
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 197
Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children 196
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 196
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 196
The need for expertise and the scientific base of evidence-based medicine 195
Total viable molds and fungal DNA in classrooms and association with respiratory health and pulmonary function of European schoolchildren 194
A murine model of asbestosis 193
Inhaled loop diuretics as potential new anti-asthmatic drugs 193
Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings 193
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 193
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis 192
Inhaler mishandling remains common in real life and is associated with reduced disease control 191
Effects of rituximab therapy on B cell differentiation and depletion 191
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 191
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 188
Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 Study. 187
Ion transport in rat tracheal epithelium in vitro. Role of capsaicin-sensitive nerves in allergic reactions 186
Allergic reactions of rat jejunal mucosa. Ion transport responses to luminal antigen and inflammatory mediators 185
Il corso AISMe: un corso integrato per problemi a piccoli gruppi per gli studenti del primo anno del Corso di Laurea in Medicina e Chirurgia 183
Luciano Vettore e Giacomo Delvecchio: “Decidere in terapia. Dialogo sul metodo nella cura” 183
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 182
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases 181
Up to date results of the Italian Studies on Respiratory Disorders in Children and the Environment (SIDRIA) 181
Interstitial vascularity in fibrosing alveolitis 180
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 180
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease 178
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 178
Road traffic and adverse respiratory effects in children. SIDRIA Collaborative Group. 178
Effects of pet exposure in the first year of life on respiratory and allergic symptoms in 7-yr-old children. The SIDRIA-2 study 177
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 176
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 175
Geriatric study in Europe on health effects of air quality in nursing homes (GERIE study) profile: objectives, study protocol and descriptive data 175
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis 174
Home oxygen therapy: re-thinking the role of devices 174
Smoking cessation in patients requiring bronchoscopy: the Bronchoscopy AntiSmoking Study (BASIS) 173
Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis 173
Bronchoalveolar lavage diagnosis of bronchiolo-alveolar carcinoma 173
Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults 172
Time Required to Rectify Inhaler Errors Among Experienced Subjects With Faulty Technique 172
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 171
A murine model of asbestosis 171
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 171
Epistemology and ethics of evidence-based medicine: putting goal-setting in the right place 170
A polymorphism in the CTGF promoter region associated with systemic sclerosis. 169
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? 169
Totale 21.423
Categoria #
all - tutte 116.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021574 0 0 0 0 0 0 0 0 0 0 283 291
2021/20222.801 199 416 214 237 100 87 123 101 135 340 292 557
2022/20233.635 239 336 464 487 313 713 103 289 384 87 137 83
2023/20242.505 110 50 238 97 124 678 814 38 24 51 36 245
2024/20255.215 273 248 456 276 694 279 157 292 352 258 562 1.368
2025/202611.104 1.005 1.645 1.150 1.205 2.471 464 1.509 349 442 599 265 0
Totale 36.418